Behavioral and neuroendocrine effects of the selective CRF₂ receptor agonists urocortin II and urocortin IIIPELLEYMOUNTER, Mary Ann; JOPPA, Margaret; LING, Nick et al.Peptides (New York, NY. 1980). 2004, Vol 25, Num 4, pp 659-666, issn 0196-9781, 8 p.Article

Urocortin 1 reduces food intake and ghrelin secretion via CRF₂ receptorsYAKABI, Koji; NOGUCHI, Masamichi; HATTORI, Tomohisa et al.American journal of physiology. Endocrinology and metabolism. 2011, Vol 64, Num 1, issn 0193-1849, E72-E82Article

CRF₂ receptor-deficiency eliminates opiate withdrawal distress without impairing stress copingINGALLINESI, M; ROUIBI, K; LE MOINE, C et al.Molecular psychiatry. 2012, Vol 17, Num 12, pp 1283-1294, issn 1359-4184, 12 p.Article

Disruption of the CRF₂ Receptor Pathway Decreases the Somatic Expression of Opiate WithdrawalPAPALEO, Francesco; GHOZLAND, Sandy; INGALLINESI, Manuela et al.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 12, pp 2878-2887, issn 0893-133X, 10 p.Article

Molecular cloning and functional expression of the mouse CRF_2(a) receptor splice variantDAUTZENBERG, Frank M; HIGELIN, Jacqueline; WILLE, Sandra et al.Regulatory peptides. 2004, Vol 121, Num 1-3, pp 89-97, issn 0167-0115, 9 p.Article

Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF₂ receptor antagonismVUONG, Shawn M; OLIVER, Harvey A; SCHOLL, Jamie L et al.Behavioural brain research. 2010, Vol 208, Num 1, pp 278-281, issn 0166-4328, 4 p.Article

Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cellsRONGJIAN ZHANG; YOUHUA XU; HONG FU et al.British journal of pharmacology. 2009, Vol 158, Num 3, pp 819-829, issn 0007-1188, 11 p.Article

Activation of the Nmociceptin/Orphanin FQ system is unable to reverse CRF₂ receptor mediated anorexia in the ratFEDELI, Amalia; POLICANI, Federica; UBALDI, Massimo et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 12, pp 3284-3291, issn 0196-9781, 8 p.Article

Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptorsYOUHUA XU; RONGJIAN ZHANG; YUANYUAN GUO et al.British journal of pharmacology. 2009, Vol 157, Num 8, pp 1368-1379, issn 0007-1188, 12 p.Article

Effect of central urocortin on carbon tetrachloride-induced acute liver injury in ratsYOKOHAMA, Shiro; YONEDA, Masashi; WATANOBE, Hajime et al.Neuroscience letters. 2001, Vol 313, Num 3, pp 149-152, issn 0304-3940Article

CRF_I and CRF₂ Receptors are Required for Potentiated Startle to Contextual but not Discrete CuesRISBROUGH, Victoria B; GEYER, Mark A; HAUGER, Richard L et al.Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 6, pp 1494-1503, issn 0893-133X, 10 p.Article

Homeostasis within the corticotropin -releasing factor system via CRF₂ receptor activation : A novel approach for the treatment of anxietyVALDEZ, Glenn R; ZORRILLA, Eric P; KOOB, George F et al.Drug development research. 2005, Vol 65, Num 4, pp 205-215, issn 0272-4391, 11 p.Article

Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in miceRISBROUGH, Victoria B; HAUGER, Richard L; PELLEYMOUNTER, Mary Ann et al.Psychopharmacologia. 2003, Vol 170, Num 2, pp 178-187, issn 0033-3158, 10 p.Article

Expression, binding, and signaling properties of CRF_2(a) receptors endogenously expressed in human retinoblastoma Y79 cells : passage-dependent regulation of functional receptorsGUTKNECHT, Eric; HAUGER, Richard L; VAN DER LINDEN, Ilse et al.Journal of neurochemistry. 2008, Vol 104, Num 4, pp 926-936, issn 0022-3042, 11 p.Article

Discovery of corticotropin releasing factor 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophyISFORT, Robert J; FENG WANG; TSCHEINER, Michelle et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 1, pp 262-265, issn 0022-2623, 4 p.Article

CRF and CRF receptors: Role in stress responsivity and other behaviorsBALER, Tracy L; VALE, Wylie W.Annual review of pharmacology and toxicology. 2004, Vol 44, pp 525-557, issn 0362-1642, 33 p.Article

SOCIAL DEFEAT STRESS ACTIVATES MEDIAL AMYGDALA CELLS THAT EXPRESS TYPE 2 CORTICOTROPIN-RELEASING FACTOR RECEPTOR mRNAFEKETE, E. M; ZHAO, Y; LI, C et al.Neuroscience. 2009, Vol 162, Num 1, pp 5-13, issn 0306-4522, 9 p.Article

Intravenous urocortin II decreases blood pressure through CRF₂ receptor in ratsCHEN, Chih-Yen; DOONG, Ming-Luen; RIVIER, Jean E et al.Regulatory peptides. 2003, Vol 113, Num 1-3, pp 125-130, issn 0167-0115, 6 p.Article

Nicotine stimulates secretion of corticosterone via both CRH and AVP receptorsLUTFY, Kabirullah; AIMIUWU, Otaren; MANGUBAT, Michael et al.Journal of neurochemistry. 2012, Vol 120, Num 5-6, pp 1108-1116, issn 0022-3042, 9 p.Article

Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodiesCHATZAKI, Ekaterini; MURPHY, Brian J; LIXIN WANG et al.Journal of neurochemistry. 2004, Vol 88, Num 1, pp 1-11, issn 0022-3042, 11 p.Article

Expression of CRF1 and CRF2 receptors in human cancersREUBI, Jean Claude; WASER, Beatrice; VALE, Wylie et al.The Journal of clinical endocrinology and metabolism. 2003, Vol 88, Num 7, pp 3312-3320, issn 0021-972X, 9 p.Article

Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonistVALDEZ, Glenn R; ZORRILLA, Eric P; RIVIER, Jean et al.Brain research. 2003, Vol 980, Num 2, pp 206-212, issn 0006-8993, 7 p.Article

Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, g-protein-coupling sensitivity and determinants of CRF₂ receptor selectivityHOARE, Sam R. J; SULLIVAN, Susan K; JUN FAN et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 3, pp 457-470, issn 0196-9781, 14 p.Article

CRF₂ receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilatorsWILEY, Katherine E; DAVENPORT, Anthony P.British journal of pharmacology. 2004, Vol 143, Num 4, pp 508-514, issn 0007-1188, 7 p.Article

Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory painMOUSA, Shaaban A; BOPAIAH, C. P; STEIN, Christoph et al.Pain (Amsterdam). 2003, Vol 106, Num 3, pp 297-307, issn 0304-3959, 11 p.Article